Journal of Cellular Biochemistry, ISSN 0730-2312, 06/2018, Volume 119, Issue 6, pp. 4890 - 4896
Chemotherapy is the most common method to treat leukemia as well as other types of human cancers. However, drug resistance has remained as the main challenge...
prednisolone | MDR1 gene | DNA methylations | acute lymphoblastic leukemia | resveratrol | ACTIVATION | PROTEIN | GLUCOCORTICOIDS | INDEPENDENT APOPTOSIS | BIOCHEMISTRY & MOLECULAR BIOLOGY | PREVENTION | PROLIFERATION | MECHANISMS | CANCER | CELL BIOLOGY | RESISTANCE | PROMOTER | Drug resistance in microorganisms | Epigenetic inheritance | Corticosteroids | Genes | Gene expression | Resveratrol | Genetic research | Genetic aspects | Acute lymphocytic leukemia | Methylation | Prednisolone | Cancer | Steroids | Acute lymphatic leukemia | Leukemia | Gene regulation | Multidrug resistance | Lymphatic leukemia | Drug resistance | MDR1 protein | Chemotherapy | Cell death | Regulatory mechanisms (biology) | DNA methylation | P-Glycoprotein | Deoxyribonucleic acid--DNA | Apoptosis
prednisolone | MDR1 gene | DNA methylations | acute lymphoblastic leukemia | resveratrol | ACTIVATION | PROTEIN | GLUCOCORTICOIDS | INDEPENDENT APOPTOSIS | BIOCHEMISTRY & MOLECULAR BIOLOGY | PREVENTION | PROLIFERATION | MECHANISMS | CANCER | CELL BIOLOGY | RESISTANCE | PROMOTER | Drug resistance in microorganisms | Epigenetic inheritance | Corticosteroids | Genes | Gene expression | Resveratrol | Genetic research | Genetic aspects | Acute lymphocytic leukemia | Methylation | Prednisolone | Cancer | Steroids | Acute lymphatic leukemia | Leukemia | Gene regulation | Multidrug resistance | Lymphatic leukemia | Drug resistance | MDR1 protein | Chemotherapy | Cell death | Regulatory mechanisms (biology) | DNA methylation | P-Glycoprotein | Deoxyribonucleic acid--DNA | Apoptosis
Journal Article
Biomedicine & Pharmacotherapy, ISSN 0753-3322, 12/2017, Volume 96, pp. 1045 - 1054
Treatment of acute lymphoblastic leukemia (ALL) fails in some cases and the side effects cause mortality in certain patients. Gallic acid (GA), a...
Asparaginase (ASP) | Gallic acid (GA) | Fas expression | Acute lymphoblastic leukemia | Apoptosis | MEDICINE, RESEARCH & EXPERIMENTAL | INVASION | THERAPY | DIETARY PHENOLICS | PHARMACOLOGY & PHARMACY | PROLIFERATION | CHILDREN | Phenols | Chemotherapy | Drug therapy, Combination | Lymphocytic leukemia | Asparaginase | Cancer
Asparaginase (ASP) | Gallic acid (GA) | Fas expression | Acute lymphoblastic leukemia | Apoptosis | MEDICINE, RESEARCH & EXPERIMENTAL | INVASION | THERAPY | DIETARY PHENOLICS | PHARMACOLOGY & PHARMACY | PROLIFERATION | CHILDREN | Phenols | Chemotherapy | Drug therapy, Combination | Lymphocytic leukemia | Asparaginase | Cancer
Journal Article
Blood, ISSN 0006-4971, 02/2009, Volume 113, Issue 8, pp. 1723 - 1729
The PI3K/AKT signaling is activated in various hematologic malignancies. We evaluated the effect of a novel, pan-AKT kinase inhibitor, GSK690693, on the...
SURVIVAL | TRANSFORMATION | ACTIVATION | PROTEIN | PATHWAY | PHOSPHORYLATION | ACUTE MYELOID-LEUKEMIA | MUTATIONS | ANTITUMOR-ACTIVITY | HEMATOLOGY | CANCER | Cell Survival - drug effects | B-Lymphocytes - cytology | Apoptosis - drug effects | CD4-Positive T-Lymphocytes - cytology | Humans | Mice, Inbred C57BL | Leukemia, B-Cell - pathology | Drug Resistance, Neoplasm | Cell Division - drug effects | B-Lymphocytes - drug effects | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Lymphoma - drug therapy | Animals | Signal Transduction - drug effects | Oxadiazoles - pharmacology | Cell Line, Tumor | Female | Leukemia, B-Cell - drug therapy | Lymphoma - pathology | Mice | Phosphorylation - drug effects | Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology | CD4-Positive T-Lymphocytes - drug effects | Proto-Oncogene Proteins c-akt - antagonists & inhibitors
SURVIVAL | TRANSFORMATION | ACTIVATION | PROTEIN | PATHWAY | PHOSPHORYLATION | ACUTE MYELOID-LEUKEMIA | MUTATIONS | ANTITUMOR-ACTIVITY | HEMATOLOGY | CANCER | Cell Survival - drug effects | B-Lymphocytes - cytology | Apoptosis - drug effects | CD4-Positive T-Lymphocytes - cytology | Humans | Mice, Inbred C57BL | Leukemia, B-Cell - pathology | Drug Resistance, Neoplasm | Cell Division - drug effects | B-Lymphocytes - drug effects | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Lymphoma - drug therapy | Animals | Signal Transduction - drug effects | Oxadiazoles - pharmacology | Cell Line, Tumor | Female | Leukemia, B-Cell - drug therapy | Lymphoma - pathology | Mice | Phosphorylation - drug effects | Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology | CD4-Positive T-Lymphocytes - drug effects | Proto-Oncogene Proteins c-akt - antagonists & inhibitors
Journal Article
BMC Cancer, ISSN 1471-2407, 09/2016, Volume 16, Issue 1, p. 746
Background: Several studies show that bone marrow (BM) microenvironment and hypoxia condition can promote the survival of leukemic cells and induce resistance...
ALL | Hypoxia | RPPA | Methotrexate | Prednisolone | Chemoresistance | SURVIVAL | APOPTOSIS | PROTEIN | PREDNISOLONE RESISTANCE | DRUG-RESISTANCE | REVERSAL | IN-VITRO | ONCOLOGY | MULTIDRUG-RESISTANCE | EXPRESSION | ASSOCIATION | Precursor Cell Lymphoblastic Leukemia-Lymphoma - metabolism | Cell Hypoxia - physiology | Cell Survival | Humans | Cell Line, Tumor | Signal Transduction - physiology | Apoptosis - physiology | Drug Resistance, Neoplasm - physiology | Complications and side effects | Prognosis | Genetic aspects | Research | Acute lymphocytic leukemia | Drug therapy | Drug resistance | Risk factors | Life Sciences | Human health and pathology | Pharmacology | Hematology | Pharmaceutical sciences | Cancer
ALL | Hypoxia | RPPA | Methotrexate | Prednisolone | Chemoresistance | SURVIVAL | APOPTOSIS | PROTEIN | PREDNISOLONE RESISTANCE | DRUG-RESISTANCE | REVERSAL | IN-VITRO | ONCOLOGY | MULTIDRUG-RESISTANCE | EXPRESSION | ASSOCIATION | Precursor Cell Lymphoblastic Leukemia-Lymphoma - metabolism | Cell Hypoxia - physiology | Cell Survival | Humans | Cell Line, Tumor | Signal Transduction - physiology | Apoptosis - physiology | Drug Resistance, Neoplasm - physiology | Complications and side effects | Prognosis | Genetic aspects | Research | Acute lymphocytic leukemia | Drug therapy | Drug resistance | Risk factors | Life Sciences | Human health and pathology | Pharmacology | Hematology | Pharmaceutical sciences | Cancer
Journal Article
JOURNAL OF THROMBOSIS AND THROMBOLYSIS, ISSN 0929-5305, 08/2019, Volume 48, Issue 2, pp. 195 - 202
Thromboembolic events are frequent and serious complications of acute lymphoblastic leukaemia treatment. The importance of chemotherapy in the pathogenesis of...
CARDIAC & CARDIOVASCULAR SYSTEMS | Thrombin generation assay | DOXORUBICIN | Extracellular vesicles | Vincristine | Microparticles | CHILDREN | THROMBIN GENERATION | Acute lymphoblastic leukemia | SURFACE | PERIPHERAL VASCULAR DISEASE | THROMBOEMBOLISM | HEMATOLOGY | Phosphatidylserine | TISSUE FACTOR | Chemotherapy | Anthracyclines | Lymphocytic leukemia | Thrombin | Phospholipids | Thromboembolism | Fluorescence microscopy | Cancer | Flow cytometry | Acute lymphatic leukemia | Leukemia | Tissue factor | Lymphatic leukemia | Thrombosis | Cell surface | Vesicles | Daunorubicin | Annexin V
CARDIAC & CARDIOVASCULAR SYSTEMS | Thrombin generation assay | DOXORUBICIN | Extracellular vesicles | Vincristine | Microparticles | CHILDREN | THROMBIN GENERATION | Acute lymphoblastic leukemia | SURFACE | PERIPHERAL VASCULAR DISEASE | THROMBOEMBOLISM | HEMATOLOGY | Phosphatidylserine | TISSUE FACTOR | Chemotherapy | Anthracyclines | Lymphocytic leukemia | Thrombin | Phospholipids | Thromboembolism | Fluorescence microscopy | Cancer | Flow cytometry | Acute lymphatic leukemia | Leukemia | Tissue factor | Lymphatic leukemia | Thrombosis | Cell surface | Vesicles | Daunorubicin | Annexin V
Journal Article
International Journal of Hematology, ISSN 0925-5710, 09/2018, Volume 108, Issue 3, pp. 312 - 318
In this study, we performed genetic analysis of 83 B cell precursor acute lymphoblastic leukemia (B-ALL) cell lines. First, we performed multiplex...
CDKN2B | BTG1 | IKZF1 | Copy number abnormality | CDKN2A | Acute lymphoblastic leukemia cell line | XENOGRAFT MODELS | PRECURSOR | KINASE | RISK | CHILDRENS ONCOLOGY GROUP | MUTATIONS | FUSIONS | INHIBITOR | HEMATOLOGY | EXPRESSION | Gene Dosage - genetics | Histone-Lysine N-Methyltransferase - genetics | Proto-Oncogene Proteins p21(ras) - genetics | Humans | Janus Kinase 2 - genetics | PAX5 Transcription Factor - genetics | DNA Copy Number Variations - genetics | Ikaros Transcription Factor - genetics | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - genetics | Cyclin-Dependent Kinase Inhibitor p18 - genetics | Cyclin-Dependent Kinase Inhibitor p15 - genetics | Myeloid-Lymphoid Leukemia Protein - genetics | Gene Deletion | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - classification | Cell Line, Tumor | Gene Rearrangement - genetics | Mutation | Neoplasm Proteins - genetics | Genetic research | Medical colleges | Genetic aspects | Acute lymphocytic leukemia | Analysis | Biotechnology | Immunoglobulins | Acute lymphatic leukemia | Copy number | Leukemia | Abnormalities | Tumor cell lines | Lymphatic leukemia | Pax5 protein | Clonal deletion | Lymphocytes B | Janus kinase 2 | Genetic analysis | Heavy chains | Cell lines | Deletion
CDKN2B | BTG1 | IKZF1 | Copy number abnormality | CDKN2A | Acute lymphoblastic leukemia cell line | XENOGRAFT MODELS | PRECURSOR | KINASE | RISK | CHILDRENS ONCOLOGY GROUP | MUTATIONS | FUSIONS | INHIBITOR | HEMATOLOGY | EXPRESSION | Gene Dosage - genetics | Histone-Lysine N-Methyltransferase - genetics | Proto-Oncogene Proteins p21(ras) - genetics | Humans | Janus Kinase 2 - genetics | PAX5 Transcription Factor - genetics | DNA Copy Number Variations - genetics | Ikaros Transcription Factor - genetics | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - genetics | Cyclin-Dependent Kinase Inhibitor p18 - genetics | Cyclin-Dependent Kinase Inhibitor p15 - genetics | Myeloid-Lymphoid Leukemia Protein - genetics | Gene Deletion | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - classification | Cell Line, Tumor | Gene Rearrangement - genetics | Mutation | Neoplasm Proteins - genetics | Genetic research | Medical colleges | Genetic aspects | Acute lymphocytic leukemia | Analysis | Biotechnology | Immunoglobulins | Acute lymphatic leukemia | Copy number | Leukemia | Abnormalities | Tumor cell lines | Lymphatic leukemia | Pax5 protein | Clonal deletion | Lymphocytes B | Janus kinase 2 | Genetic analysis | Heavy chains | Cell lines | Deletion
Journal Article
Journal of Experimental and Clinical Cancer Research, ISSN 1756-9966, 06/2019, Volume 38, Issue 1, pp. 269 - 12
BackgroundDrug-resistant cell lines, established from drug-sensitive cell lines by drug exposure in vitro, are the most useful cancer models in studies on the...
Hypoxia | Cell line | Glucocorticoid resistance | Method | Acute lymphoblastic leukemia | IN-VITRO | METABOLISM | ONCOLOGY | BONE-MARROW | AMPK | STRESS | Parenting | Usage | Corticosteroids | Analysis | Acute lymphocytic leukemia | Drug resistance | Methods
Hypoxia | Cell line | Glucocorticoid resistance | Method | Acute lymphoblastic leukemia | IN-VITRO | METABOLISM | ONCOLOGY | BONE-MARROW | AMPK | STRESS | Parenting | Usage | Corticosteroids | Analysis | Acute lymphocytic leukemia | Drug resistance | Methods
Journal Article
CANCER CELL INTERNATIONAL, ISSN 1475-2867, 04/2019, Volume 19, Issue 1, p. 113
BackgroundAlthough contemporary chemotherapy has improved the cure rate of childhood acute lymphoblastic leukemia (ALL) to nearly 90%, relapsed/refractory ALL...
Chromosome 9p deletion | SURVIVAL | Leukemia cell line | Chromosome 17p deletion | ABNORMALITIES | MONOSOMAL KARYOTYPE | CLASSIFICATION | CYTOGENETICS | CHILDREN | RELAPSE | Acute lymphoblastic leukemia | ONCOLOGY | HIGH-RISK | Complex karyotype | PROGNOSTIC-SIGNIFICANCE | Cell culture | Flow cytometry | Pediatrics | Trisomy | Leukemia | Xenotransplantation | Single-nucleotide polymorphism | Culture techniques | Blood | Xenografts | Children | Chromosomes | Medical research | Phenotypes | Acute lymphatic leukemia | Multidrug resistance | Cyclin-dependent kinases | Tumorigenicity | Lymphatic leukemia | Patients | Polymerase chain reaction | Refractory materials | Chemotherapy | Lymphocytes B | Chromosome 9 | Medical prognosis | Cell lines | Cytogenetics | Mice | Lymphomas | Asparaginase | Cancer | Tumors
Chromosome 9p deletion | SURVIVAL | Leukemia cell line | Chromosome 17p deletion | ABNORMALITIES | MONOSOMAL KARYOTYPE | CLASSIFICATION | CYTOGENETICS | CHILDREN | RELAPSE | Acute lymphoblastic leukemia | ONCOLOGY | HIGH-RISK | Complex karyotype | PROGNOSTIC-SIGNIFICANCE | Cell culture | Flow cytometry | Pediatrics | Trisomy | Leukemia | Xenotransplantation | Single-nucleotide polymorphism | Culture techniques | Blood | Xenografts | Children | Chromosomes | Medical research | Phenotypes | Acute lymphatic leukemia | Multidrug resistance | Cyclin-dependent kinases | Tumorigenicity | Lymphatic leukemia | Patients | Polymerase chain reaction | Refractory materials | Chemotherapy | Lymphocytes B | Chromosome 9 | Medical prognosis | Cell lines | Cytogenetics | Mice | Lymphomas | Asparaginase | Cancer | Tumors
Journal Article
Biomedicine & Pharmacotherapy, ISSN 0753-3322, 2016, Volume 84, pp. 1266 - 1273
Highlights • Aydın propolis regulates expression levels of both oncogenic and tumor suppressor miRNAs. • Aydın propolis induces apoptotic cell death in ALL...
Internal Medicine | Medical Education | miRNA | Acute lymphoblastic leukemia | Propolis | Apoptosis | MEDICINE, RESEARCH & EXPERIMENTAL | ACID PHENETHYL ESTER | MICRORNAS | POLYPHENOLIC COMPOUNDS | BETA | GROWTH | PHARMACOLOGY & PHARMACY | EXPRESSION | EXTRACT | Apoptosis - drug effects | Humans | Carcinogenesis - genetics | Gene Expression Regulation, Leukemic - drug effects | MicroRNAs - metabolism | Gene Expression Profiling | Carcinogenesis - pathology | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | Leukemia, B-Cell - genetics | Cell Line, Tumor | Inhibitory Concentration 50 | Propolis - pharmacology | MicroRNAs - genetics | Epigenetic inheritance | MicroRNA | Cell death | Analysis | Medical genetics | Honeybee | Chemotherapy | Lymphocytic leukemia | Cancer
Internal Medicine | Medical Education | miRNA | Acute lymphoblastic leukemia | Propolis | Apoptosis | MEDICINE, RESEARCH & EXPERIMENTAL | ACID PHENETHYL ESTER | MICRORNAS | POLYPHENOLIC COMPOUNDS | BETA | GROWTH | PHARMACOLOGY & PHARMACY | EXPRESSION | EXTRACT | Apoptosis - drug effects | Humans | Carcinogenesis - genetics | Gene Expression Regulation, Leukemic - drug effects | MicroRNAs - metabolism | Gene Expression Profiling | Carcinogenesis - pathology | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | Leukemia, B-Cell - genetics | Cell Line, Tumor | Inhibitory Concentration 50 | Propolis - pharmacology | MicroRNAs - genetics | Epigenetic inheritance | MicroRNA | Cell death | Analysis | Medical genetics | Honeybee | Chemotherapy | Lymphocytic leukemia | Cancer
Journal Article
PLoS ONE, ISSN 1932-6203, 09/2013, Volume 8, Issue 9, p. e74768
We previously reported that fenretinide (4-HPR) was cytotoxic to acute lymphoblastic leukemia (ALL) cell lines in vitro in association with increased levels of...
DIHYDROCERAMIDE DESATURASE | CANCER-CELLS | C2-CERAMIDE | MAMMALIAN CERAMIDE SYNTHASES | METABOLISM | MULTIDISCIPLINARY SCIENCES | INVOLVEMENT | N-(4-HYDROXYPHENYL)RETINAMIDE-INDUCED APOPTOSIS | SPHINGOSINE | SPHINGOLIPIDS | FENRETINIDE | Sphingolipids - chemistry | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Fatty Acids - chemistry | Reactive Oxygen Species | Humans | Ceramides - chemistry | Mitochondria - metabolism | Antineoplastic Agents - chemistry | Autophagy | Sphingosine - analogs & derivatives | DNA Fragmentation | Cell Line, Tumor | Culture Media - chemistry | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - metabolism | Sphingosine - chemistry | Ceramides | Acute lymphocytic leukemia | Plant lipids | T cells | Cell death | Fatty acids | Health sciences | Biotechnology | Reactive oxygen species | Toxicity | Leukemia | Cytotoxicity | Lipids | Biochemistry | Lymphocytes T | Desaturase | Fragmentation | Synthesis | Sphinganine | DNA fragmentation | Supplementation | Drug dosages | Deoxyribonucleic acid--DNA | Enzymes | Acute lymphatic leukemia | Ethanol | Caspase | Tumor cell lines | Lymphatic leukemia | Gene expression | Medicine | Testing laboratories | Cell lines | Phagocytosis | Cancer | Apoptosis | Deoxyribonucleic acid | DNA
DIHYDROCERAMIDE DESATURASE | CANCER-CELLS | C2-CERAMIDE | MAMMALIAN CERAMIDE SYNTHASES | METABOLISM | MULTIDISCIPLINARY SCIENCES | INVOLVEMENT | N-(4-HYDROXYPHENYL)RETINAMIDE-INDUCED APOPTOSIS | SPHINGOSINE | SPHINGOLIPIDS | FENRETINIDE | Sphingolipids - chemistry | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Fatty Acids - chemistry | Reactive Oxygen Species | Humans | Ceramides - chemistry | Mitochondria - metabolism | Antineoplastic Agents - chemistry | Autophagy | Sphingosine - analogs & derivatives | DNA Fragmentation | Cell Line, Tumor | Culture Media - chemistry | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - metabolism | Sphingosine - chemistry | Ceramides | Acute lymphocytic leukemia | Plant lipids | T cells | Cell death | Fatty acids | Health sciences | Biotechnology | Reactive oxygen species | Toxicity | Leukemia | Cytotoxicity | Lipids | Biochemistry | Lymphocytes T | Desaturase | Fragmentation | Synthesis | Sphinganine | DNA fragmentation | Supplementation | Drug dosages | Deoxyribonucleic acid--DNA | Enzymes | Acute lymphatic leukemia | Ethanol | Caspase | Tumor cell lines | Lymphatic leukemia | Gene expression | Medicine | Testing laboratories | Cell lines | Phagocytosis | Cancer | Apoptosis | Deoxyribonucleic acid | DNA
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 4/2008, Volume 100, Issue 8, pp. 580 - 595
Background ABT-737 is a pan-Bcl-2 inhibitor that has a wide range of single-agent activity against acute lymphoblastic leukemia (ALL) cell lines and...
BREAST-CANCER | BCL-X-L | LUNG-CANCER | RETINOIC ACID | ONCOLOGY | PHASE-I TRIAL | INDUCED APOPTOSIS | CYTOTOXICITY ASSAY | ACUTE MYELOID-LEUKEMIA | FAMILY PROTEINS | BH3 MIMETIC ABT-737 | Gene Expression Regulation, Enzymologic - drug effects | Phosphorylation | Reactive Oxygen Species - metabolism | Humans | Immunoblotting | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Precursor Cell Lymphoblastic Leukemia-Lymphoma - metabolism | Proto-Oncogene Proteins c-bcl-2 - metabolism | Caspases - metabolism | Biphenyl Compounds - pharmacology | Nitrophenols - pharmacology | Antineoplastic Agents - pharmacology | Gene Expression Regulation, Neoplastic - drug effects | JNK Mitogen-Activated Protein Kinases - genetics | Mitochondrial Membranes | Cytochromes c - metabolism | Gene Silencing | Fenretinide - pharmacology | Reverse Transcriptase Polymerase Chain Reaction | Sulfonamides - pharmacology | Piperazines - pharmacology | Drug Synergism | Proto-Oncogene Proteins c-bcl-2 - drug effects | Cell Line, Tumor | Enzyme Activation | Apoptosis | Antimitotic agents | Dosage and administration | Acute lymphocytic leukemia | Drug therapy | Antineoplastic agents | Proteins | Medical research | Toxicity | Leukemia | Cells | Index Medicus
BREAST-CANCER | BCL-X-L | LUNG-CANCER | RETINOIC ACID | ONCOLOGY | PHASE-I TRIAL | INDUCED APOPTOSIS | CYTOTOXICITY ASSAY | ACUTE MYELOID-LEUKEMIA | FAMILY PROTEINS | BH3 MIMETIC ABT-737 | Gene Expression Regulation, Enzymologic - drug effects | Phosphorylation | Reactive Oxygen Species - metabolism | Humans | Immunoblotting | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Precursor Cell Lymphoblastic Leukemia-Lymphoma - metabolism | Proto-Oncogene Proteins c-bcl-2 - metabolism | Caspases - metabolism | Biphenyl Compounds - pharmacology | Nitrophenols - pharmacology | Antineoplastic Agents - pharmacology | Gene Expression Regulation, Neoplastic - drug effects | JNK Mitogen-Activated Protein Kinases - genetics | Mitochondrial Membranes | Cytochromes c - metabolism | Gene Silencing | Fenretinide - pharmacology | Reverse Transcriptase Polymerase Chain Reaction | Sulfonamides - pharmacology | Piperazines - pharmacology | Drug Synergism | Proto-Oncogene Proteins c-bcl-2 - drug effects | Cell Line, Tumor | Enzyme Activation | Apoptosis | Antimitotic agents | Dosage and administration | Acute lymphocytic leukemia | Drug therapy | Antineoplastic agents | Proteins | Medical research | Toxicity | Leukemia | Cells | Index Medicus
Journal Article
Research in pharmaceutical sciences, ISSN 1735-5362, 02/2019, Volume 14, Issue 1, pp. 55 - 63
Treatment of acute lymphoblastic leukemia (ALL) has been promising in last decades, but side effects still persist and searching for the least toxic agents...
Care and treatment | Lymphocytic leukemia | RNA | Tumor necrosis factor | Cancer | Apoptosis | Flowcytometry | Fas | Acute lymphoblastic leukemia | Original | RT-PCR | Pterostilbene
Care and treatment | Lymphocytic leukemia | RNA | Tumor necrosis factor | Cancer | Apoptosis | Flowcytometry | Fas | Acute lymphoblastic leukemia | Original | RT-PCR | Pterostilbene
Journal Article
Leukemia Research, ISSN 0145-2126, 2014, Volume 39, Issue 3, pp. 342 - 347
Highlights • FoxM1 mRNA is highly expressed in T-cell acute lymphoblastic leukemia cell line (Jurkat cells). • Targeting FoxM1 by siomycin A and dexamethasone...
Hematology, Oncology and Palliative Medicine | Jurkat cells | Dexamethasone | FoxM1 | Siomycin A | T-cell acute lymphoblastic leukemia | FORKHEAD BOX M1B | OXIDATIVE STRESS | PHOSPHORYLATION | FACTOR TRIDENT | PROLIFERATION | CANCER | ONCOLOGY | HEMATOLOGY | PROGRESSION | PROGRAM | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - pathology | Antineoplastic Agents, Hormonal - pharmacology | Apoptosis - drug effects | Humans | RNA, Messenger - genetics | Antineoplastic Combined Chemotherapy Protocols | Forkhead Transcription Factors - genetics | Reverse Transcriptase Polymerase Chain Reaction | Blotting, Western | Peptides - pharmacology | Dexamethasone - pharmacology | Forkhead Transcription Factors - metabolism | Cell Proliferation - drug effects | Forkhead Transcription Factors - antagonists & inhibitors | Gene Expression Regulation, Neoplastic - drug effects | Tumor Cells, Cultured | Cell Cycle - drug effects | Forkhead Box Protein M1 | Real-Time Polymerase Chain Reaction | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - metabolism | Acute lymphocytic leukemia | RNA | T cells
Hematology, Oncology and Palliative Medicine | Jurkat cells | Dexamethasone | FoxM1 | Siomycin A | T-cell acute lymphoblastic leukemia | FORKHEAD BOX M1B | OXIDATIVE STRESS | PHOSPHORYLATION | FACTOR TRIDENT | PROLIFERATION | CANCER | ONCOLOGY | HEMATOLOGY | PROGRESSION | PROGRAM | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - pathology | Antineoplastic Agents, Hormonal - pharmacology | Apoptosis - drug effects | Humans | RNA, Messenger - genetics | Antineoplastic Combined Chemotherapy Protocols | Forkhead Transcription Factors - genetics | Reverse Transcriptase Polymerase Chain Reaction | Blotting, Western | Peptides - pharmacology | Dexamethasone - pharmacology | Forkhead Transcription Factors - metabolism | Cell Proliferation - drug effects | Forkhead Transcription Factors - antagonists & inhibitors | Gene Expression Regulation, Neoplastic - drug effects | Tumor Cells, Cultured | Cell Cycle - drug effects | Forkhead Box Protein M1 | Real-Time Polymerase Chain Reaction | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - metabolism | Acute lymphocytic leukemia | RNA | T cells
Journal Article
Natural Product Research, ISSN 1478-6419, 06/2019, Volume 33, Issue 11, pp. 1633 - 1636
Anacardium occidentale leaves are used in folk medicine due its therapeutic properties attributed to phenolic compounds. Therefore, this study was undertaken...
polyphenols | apoptosis | Cashew | leukaemia cells | CHEMISTRY, MEDICINAL | CHEMISTRY, APPLIED | Leaves | Acute lymphatic leukemia | Toxicity | Leukemia | Cell lines | Cell cycle | Phenols | Cytotoxicity | Drug development | Phenolic compounds | Apoptosis | Plant extracts
polyphenols | apoptosis | Cashew | leukaemia cells | CHEMISTRY, MEDICINAL | CHEMISTRY, APPLIED | Leaves | Acute lymphatic leukemia | Toxicity | Leukemia | Cell lines | Cell cycle | Phenols | Cytotoxicity | Drug development | Phenolic compounds | Apoptosis | Plant extracts
Journal Article